CombinatoRx amends IPO

CombinatoRx (Boston, Mass.) updated its previously postponed IPO, and is now looking to sell 6 million shares at $10-$12 through SG Cowen; Pacific Growth; Lazard; and A.G. Edwards. In March, CombinatoRx postponed the offering, citing market conditions. At the time, the deal was to be underwritten by SG Cowen; Pacific Growth; SunTrust Robinson Humphrey; and A.G. Edwards. An $11 deal price would raise $66 million and value CombinatoRx at $224 million. The company originally filed to raise up to $100 million in December 2004. ...